BR0015398A - Vacinas para mycoplasma bovis e processos de uso - Google Patents

Vacinas para mycoplasma bovis e processos de uso

Info

Publication number
BR0015398A
BR0015398A BR0015398-2A BR0015398A BR0015398A BR 0015398 A BR0015398 A BR 0015398A BR 0015398 A BR0015398 A BR 0015398A BR 0015398 A BR0015398 A BR 0015398A
Authority
BR
Brazil
Prior art keywords
vaccines
bovis
infections
processes
mycoplasma
Prior art date
Application number
BR0015398-2A
Other languages
English (en)
Inventor
Joan D Leonard
Robert W Tully
Original Assignee
Biomune
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomune filed Critical Biomune
Publication of BR0015398A publication Critical patent/BR0015398A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"VACINAS PARA MYCOPLASMA BOVIS E PROCESSOS DE USO". é descrita a invenção de novas vacinas eficazes contra Mycoplasma bovis para uso em gado. Estas vacinas demonstram nao possuir efeitos colaterais indesejáveis e protegem contra doença relacionada a M. bovis , tal como, mastite contagiosa, pneumonia respiratória, infecções das juntas, ceratoconjuntivite e infecções do ouvido médio. As novas vacinas também diminuem os efeitos das infecções por M.bovis na produção do leite, ganho de peso e saúde do animal. Processos de diagnóstico, caracterização e tratamento de infecções por M.bovis como biótipos específicos são também revelados. As composições de vacina feitas de acordo com a invenção podem ser tanto de variedade atenuada ou inativada. As vacinas podem também incluir antígenos de outros agentes patogênicos, de modo a prover uma resposta imunogênica protetora para doenças que não aquelas causadas por M.bovis.
BR0015398-2A 1999-11-08 2000-11-08 Vacinas para mycoplasma bovis e processos de uso BR0015398A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16428699P 1999-11-08 1999-11-08
PCT/US2000/042000 WO2001034189A2 (en) 1999-11-08 2000-11-08 Vaccines for mycoplasma bovis and methods of use

Publications (1)

Publication Number Publication Date
BR0015398A true BR0015398A (pt) 2002-06-25

Family

ID=22593810

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0015398-2A BR0015398A (pt) 1999-11-08 2000-11-08 Vacinas para mycoplasma bovis e processos de uso

Country Status (10)

Country Link
US (7) US7943153B1 (pt)
EP (1) EP1229929A2 (pt)
JP (1) JP2003513935A (pt)
AU (1) AU782508B2 (pt)
BR (1) BR0015398A (pt)
CA (1) CA2390613A1 (pt)
IL (1) IL149471A0 (pt)
MX (1) MXPA02004627A (pt)
WO (1) WO2001034189A2 (pt)
ZA (1) ZA200203622B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1229929A2 (en) * 1999-11-08 2002-08-14 Biomune VACCINES FOR i MYCOPLASMA BOVIS /i AND METHODS OF USE
GB0110851D0 (en) * 2001-05-03 2001-06-27 Mini Agriculture & Fisheries Vaccine
US20030147914A1 (en) * 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
JP2005500845A (ja) * 2001-08-28 2005-01-13 ファイザー・プロダクツ・インク マイコプラズマ・ボビスチャレンジモデル並びにマイコプラズマ・ボビスの投与方法及び肺炎性肺病変の誘発方法
WO2008030619A2 (en) * 2006-09-07 2008-03-13 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
UY31437A1 (es) 2007-10-29 2009-05-29 Vacuna de mycoplasma bovis y métodos de uso de la misma
RU2489164C9 (ru) * 2007-11-06 2014-01-20 ВАЙЕТ ЭлЭлСи АВИРУЛЕНТНАЯ АДЪЮВАНТНАЯ ЖИВАЯ ВАКЦИНА ПРОТИВ Mycoplasma hyopneumoniae
EP2163239A1 (de) * 2008-05-27 2010-03-17 Qiagen GmbH Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung
EP2320943B1 (en) * 2008-07-03 2016-02-17 Iowa State University Research Foundation, Inc. Cattle vaccines
EP2362780B1 (en) 2008-10-31 2019-12-25 Boehringer Ingelheim Animal Health USA Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
TWI583403B (zh) 2009-06-04 2017-05-21 國立感染症研究所 黴漿菌感染症用疫苗
CN102648003B (zh) 2009-10-09 2016-01-13 儿童医疗中心有限公司 选择性裂解的全细胞疫苗
WO2012041635A1 (en) * 2010-09-29 2012-04-05 Universite De Liege Combination of an agonistic anti-cd40 monoclonal antibody or a cd40 ligand and inactivated or attenuated bacteria for use in the treatment and/or prevention of mastitis
US9052315B2 (en) 2012-05-09 2015-06-09 Advanced Animal Diagnostics, Inc. Rapid detection of analytes in liquid samples
US10359614B2 (en) 2012-07-03 2019-07-23 Advanced Animal Diagnostics, Inc. Diagnostic apparatus
HUE059179T2 (hu) 2012-09-10 2022-10-28 Galenbio Inc Vízimadárban Mycoplasma-fertõzés megelõzésére szolgáló oltóanyag
US9797893B2 (en) 2013-05-09 2017-10-24 Advanced Animal Diagnostics, Inc. Rapid detection of analytes in liquid samples
WO2017030901A1 (en) 2015-08-14 2017-02-23 Zoetis Services Llc Mycoplasma bovis compositions
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN113040094B (zh) * 2021-03-18 2022-06-21 中国农业大学 一种牛支原体性小鼠乳腺炎模型的构建方法及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1188985A (en) 1980-07-01 1985-06-18 Edward J. Stott Production of viral antigens
US4425330A (en) * 1981-05-20 1984-01-10 Cornell Research Foundation, Inc. Bovine mastitis vaccine and method for detecting efficacy thereof
US4517394A (en) * 1983-07-05 1985-05-14 W. R. Grace & Co. Preparation of nitro compounds by vapor phase nitration of carboxylic acids
US5178860A (en) 1989-09-01 1993-01-12 Coopers Animal Health Limited Adjuvant complexes and vaccine made therefrom
US4981684A (en) 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
CA2057946A1 (en) * 1990-12-20 1992-06-21 Michael M. Thackeray Electrochemical cell
US5316875A (en) * 1991-07-19 1994-05-31 Matsushita Electric Industrial Co., Ltd. Secondary battery with nonaqueous electrolyte and method of manufacturing same
US5338543A (en) 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5585098A (en) 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
DE69528450T2 (de) * 1994-02-18 2003-01-23 Solidose L L C Impfung von tieren mit getrockneten pelletierten biologischen materialien
JP3702353B2 (ja) * 1996-05-24 2005-10-05 日本電池株式会社 リチウム電池用正極活物質の製造方法およびリチウム電池
EP1229929A2 (en) * 1999-11-08 2002-08-14 Biomune VACCINES FOR i MYCOPLASMA BOVIS /i AND METHODS OF USE
DE29921392U1 (de) 1999-12-06 2000-03-16 Felgentraeger & Co Oeko Chem U Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6677082B2 (en) * 2000-06-22 2004-01-13 The University Of Chicago Lithium metal oxide electrodes for lithium cells and batteries
US6680143B2 (en) * 2000-06-22 2004-01-20 The University Of Chicago Lithium metal oxide electrodes for lithium cells and batteries
JP3500424B2 (ja) * 2000-08-31 2004-02-23 独立行政法人産業技術総合研究所 単相リチウムフェライト系複合酸化物
US6548069B2 (en) 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Also Published As

Publication number Publication date
MXPA02004627A (es) 2004-02-18
US20080069842A9 (en) 2008-03-20
US7416734B2 (en) 2008-08-26
US7429389B2 (en) 2008-09-30
EP1229929A2 (en) 2002-08-14
US20070077260A1 (en) 2007-04-05
US20080226671A1 (en) 2008-09-18
AU2622501A (en) 2001-06-06
WO2001034189A2 (en) 2001-05-17
US7943153B1 (en) 2011-05-17
AU782508B2 (en) 2005-08-04
ZA200203622B (en) 2003-07-30
US20090263427A1 (en) 2009-10-22
WO2001034189A3 (en) 2001-12-27
US20050053627A1 (en) 2005-03-10
US20050118200A1 (en) 2005-06-02
IL149471A0 (en) 2002-11-10
JP2003513935A (ja) 2003-04-15
CA2390613A1 (en) 2001-05-17
US20090220550A1 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
BR0015398A (pt) Vacinas para mycoplasma bovis e processos de uso
Syed Coronavirus: a mini-review
CA2339089A1 (en) Cold-adapted equine influenza viruses
BR0111366A (pt) Vacina de poxvìrus recombinante do vìrus da sìndrome respiratória e reprodutiva de porcino (prrsv)
BRPI0511776A (pt) vìrus atenuado de influenza de suìnos, formulação imunogênica, formulação farmacêutica, métodos para imunizar ou induzir uma resposta imune em um porco, para tratar uma infecção por vìrus de influenza de suìnos em um porco, para tratar cáncer em um porco, e para produzir uma formulação imunogênica, célula, linhagem de células de porco, e, ovo embrionado
Koprowski et al. Propagation of hog cholera virus in rabbits
MXPA03011815A (es) Vacuna de micoplasma bovis y metodos para reducir la neumonia en animales.
WO2001060849A3 (en) Cold-adapted equine influenza viruses
JP2003513935A5 (pt)
EP3661546B1 (en) A vaccine for protection against streptococcus suis
BR112021008646A2 (pt) uma vacina para proteção contra streptococcus suis
BR112022019207A2 (pt) Composições de vacina para coronavírus e métodos de uso das mesmas
AU4930001A (en) Cold-adapted equine influenza viruses
CA2931139A1 (en) Swine vaccine against prrs and lawsonia intracellularis
Stokka et al. Feedlot vaccination: does it really matter?
JP2021506777A (ja) レンサ球菌感染防御のためのワクチン
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
JP3109886B2 (ja) 経鼻接種用ワクチン
DE69033503T2 (de) Nukleotidsequenzen und polypeptide von pestivirus, im einzelnen vom schweine-cholera-virus
BR0007966A (pt) Composições e métodos para o tratamento e a prevenção de infecção bacteriana patogênica com base na função essencial da metilação do dna na virulência bacteriana
BRPI0412923A (pt) composição farmacêutica dispersìvel para o tratamento de mastite e de distúrbios óticos
Blackmore et al. Alternative strategies for the control of leptospirosis in dairy herds
RU94028204A (ru) Препарат "уберсан" для лечения мастита у сельскохозяйственных животных
BR0212279A (pt) Vacina obtida de linhagem celular para vìrus causador de anemia em galinhas
BRPI0416178A (pt) método de incorporação de antìgeno em vesìculas de membrana externa de bactérias neisseria e formulações de vacina resultantes

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11 E 13 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.